Janel Huffman - Concepedia

Author

Janel Huffman

Fate Therapeutics (United States)

Also Known As

Janel Huffman

Publications

413

Citations

H-Index

Concepts

All Affiliations

Fate Therapeutics (United States)University of Minnesota Karolinska Institutet University of Chicago Oslo University Hospital

About

Janel Huffman is an author at Fate Therapeutics (United States) specializing in immunology, cell biology, and natural killer cells.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	147
2	Cell Biology	1	1	147
3	Cellular Therapies	1	1	147
4	Immunology	1	1	147
5	Autoimmunity	1	1	147

Janel Huffman

Publications

390

Citations

H-Index

Page 1

	Year	Citations
Harnessing features of adaptive NK cells to generate iPSC-derived NK cells for enhanced immunotherapy Karrune Woan, Hansol Kim, Ryan Bjordahl, Cell stem cell Cell TherapyAdaptive Nk CellsAdaptive Immune SystemImmunologyAutoimmunity	2021	147
Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia Frank Cichocki, Jodie P. Goodridge, Ryan Bjordahl, Blood	2022	79
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma Frank Cichocki, Ryan Bjordahl, Jodie P. Goodridge, Nature Communications	2022	71
DNA methylation signatures in airway cells from adult children of asthmatic mothers reflect subtypes of severe asthma Kevin M. Magnaye, Selene M. Clay, Jessie Nicodemus‐Johnson, Proceedings of the National Academy of Sciences	2022	31
FT576: A Novel Multiplexed Engineered Off-the-Shelf Natural Killer Cell Immunotherapy for the Dual-Targeting of CD38 and Bcma for the Treatment of Multiple Myeloma Ryan Bjordahl, Svetlana Gaidarova, Jode Goodridge, Blood	2019	29
A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma Kevin M. Magnaye, Katherine A. Naughton, Janel Huffman, European Respiratory Journal	2021	17
FT538: Preclinical Development of an Off-the-Shelf Adoptive NK Cell Immunotherapy with Targeted Disruption of CD38 to Prevent Anti-CD38 Antibody-Mediated Fratricide and Enhance ADCC in Multiple Myeloma When Combined with Daratumumab Ryan Bjordahl, Svetlana Gaidarova, Karrune Woan, Blood	2019	16

Page 1